Press Release: Circa Group and Sanoosa Sign MoU to Focus on Cancer Molecule

Circa master logo PMSBiotechnology companies Circa Group Pty. Ltd. and Sanoosa Pty. Ltd. have signed a Memorandum of Understanding (MoU) to continue developing molecules showing early-stage promise in inhibiting protein-protein interactions, which play a key role in disease development.

Targeting such protein complexes directly allows for a more specific response and attacks early disease promoting events.

Read more ...

Brand Perspectives
On Biomaterials


Download Now